Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.42	0.2	0.35	0.69	1.68
Short-Term Investments	0.24	0.07	0.06	0.11	0.04
Cash & Short-Term Investments	0.67	0.26	0.42	0.8	1.72
Cash Growth	154.42%	-37.19%	-47.92%	-53.39%	188.31%
Accounts Receivable	3.86	3.33	3.16	2.21	2.62
Other Receivables	0.05	0.09	0.18	0.11	0.07
Total Trade Receivables	3.9	3.42	3.33	2.32	2.69
Inventory	0.01	-	-	-	-
Other Current Assets	0.01	0.02	0.01	0	0
Total Current Assets	4.59	3.7	3.76	3.12	4.4
Net Property, Plant & Equipment	2.2	2.32	2.44	2.53	2.56
Other Intangible Assets	3.27	4.18	4.97	6.39	5.84
Goodwill	0.82	1.46	2.1	2.74	3.37
Long-Term Investments	0.25	0.45	0.57	0.37	0.36
Other Long-Term Assets	2.43	2.67	2.76	3.33	3.33
Total Assets	13.56	14.78	16.61	18.47	19.88

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.2	0.2	0.31	0.4	0.3
Accrued Expenses	1.34	1.61	1.33	1.17	1.78
Short-Term Debt	1.69	2.73	1.96	1.96	1.44
Current Portion of Leases	0.02	0.02	0.01	-	-
Unearned Revenue	0.02	-	-	0	0.02
Other Current Liabilities	0	0	0	0	0
Total Current Liabilities	3.27	4.55	3.61	3.54	3.55
Long-Term Debt	2.29	2.38	5.13	9.77	10.58
Long-Term Leases	0.01	0.01	0.03	-	-
Other Long-Term Liabilities	1.03	1.24	1.31	1.3	1.4
Total Long-Term Liabilities	3.33	3.63	6.46	11.07	11.98
Total Liabilities	6.6	8.17	10.08	14.6	15.54

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.64	3.3	2.89	2.72	2.29
Treasury Stock	-0.02	-0.03	-0.05	-0.03	-0.1
Additional Paid-in Capital	101.93	100.08	97.44	96.65	95.43
Accumulated Other Comprehensive Income	0.79	0.78	0.86	0.66	0.75
Retained Earnings	-99.37	-97.52	-94.46	-95.97	-93.89
Total Common Shareholders' Equity	6.18	5.83	5.82	3.36	3.74
Minority Interest	-0	-0	-0.15	-0.15	-0.15
Shareholders' Equity	6.96	6.61	6.53	3.87	4.34
Total Liabilities & Equity	13.56	14.78	16.61	18.47	19.88

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.01	5.13	7.13	11.73	12.03
Net Cash (Debt)	-3.34	-4.87	-6.71	-10.93	-10.31
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.05	-0.07	-0.12	-0.19	-0.23
Book Value	6.18	5.83	5.82	3.36	3.74
Book Value Per Share	0.08	0.09	0.10	0.06	0.08
Tangible Book Value	2.09	0.19	-1.25	-5.77	-5.48
Tangible Book Value Per Share	0.03	0.00	-0.02	-0.10	-0.12

Data Source: Fiscal.ai Last updated: Mar 27, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 3, 2026

Data Sources Report a data error